| no | title  | author | date |
|---|
| 6.07.4.60/54 |  177Lu productie met de SHINE technologie | Antonia Denkova, Robin de Kruijff, B.Wolterbeek |
March 2022 |
| 6.07.4.60/36 | 2016 Medical Isotope Supply Review | NEA |
June 2016 |
| 6.07.4.60/29 | 2017 Medical Isotope Supply Review: Mo/Tc Market Demand and Production Capacity Projection 2017-2022 | OECD, NEA |
April 2017 |
| 6.07.4.60/11 | A Silent Crisis. Cancer Treatment in Developing Countries | IAEA |
2003 |
| 6.07.4.60/14 | Aanbevelingen nucleaire geneeskunde | R.O.Boer, K.S.Wiarda, NVNG |
1996 |
| 6.07.4.60/35 | Alternatives for the production of medical isotopes | Greenpeace Netherlands, Profundo, J.W.van Gelder, A.Herder |
March 2010 |
| 6.07.4.60/07 | An assessment of "Low-Level" Radioactive Waste Options for Hospitals and Biomedical Research Institutions in New York | Hamilto, Physicians for Social Responsibility |
July 1996 |
| 6.07.4.60/10 | Annual Congress of European Association of Nuclear Medicine 23-27 August | EANM'03 |
August 2003 |
| 6.07.4.60/53 | Co-ordinated Approach to the Development and Supply of Radionuclides in the EU | N. Mario, A. Kolmayer, G. Turquet, A. Vallée, P.E. Goethals |
October 2021 |
| 6.07.4.60/26 | Co-production of medical radioisotopes in the proposed Accelerator Production of Tritium Facility | LANL |
December 1998 |
| 6.07.4.60/31 | Cyclotron Based Production of Technetium-99m | IAEA |
June 2017 |
| 6.07.4.60/06 | De betekenis van Petten voor de radiofarmaceutische markt | J.W.van Gelder, Greenpeace |
September 2000 |
| 6.07.4.60/45 | Emissions from Fission-Based Medical Isotope Production and their Effects on the International Monitoring System | Th.W.Bowyer |
May 2015 |
| 6.07.4.60/46 | European Research Reactor Position Paper. Scenario for sustainable Molybdenum-99 production in Europe | CEA, NCBJ, NRG, PALLAS, RCR, SCK•CEN, TUM |
June 2018 |
| 6.07.4.60/32 | Feasibility of Producing Molybdenum-99 on a Small Scale Using Fission of Low Enriched Uranium or Neutron Activation of Natural Molybdenum | IAEA |
January 2015 |
| 6.07.4.60/25 | Future Supply of Medical Radioisotopes for the UK Report 2014 | British Nuclear Medicine Society, Science & Technology Facilities Council |
November 2014 |
| 6.07.4.60/08 | Het testen van ingekapselde radium bronnen op lek | L.B.Beentjes, IRI |
September 1973 |
| 6.07.4.60/50 | Innovatie in medische isotopenproductie zonder kernreactor | Laka, H.vd Keur |
February 2021 |
| 6.07.4.60/03 | Inventarisatie van röntgentoestellen in NL ziekenhuizen | Directie Stralenbescherming |
1985 |
| 6.07.4.60/43 | Isotopic noble gas signatures released from medical isotope production facilities- Simulations and measurements | P.Saey, Th.W.Bowyer, A.Ringbom |
April 2010 |
| 6.07.4.60/05 | Jaarverslag 1996 Academisch Ziekenhuis Leiden | Dienst veiligheid Stralenbescherming |
March 1997 |
| 6.07.4.60/12 | Krebsbehandlung mit Neutronen fragwürdig | Karin Wurzbacher, Umweltinstitut |
October 2003 |
| 6.07.4.60/49 | Leveringszekerheid voor medische radionucliden - aanvullingen 2020 | Roobol, Rosenbaum, de Waard, RIVM |
December 2020 |
| 6.07.4.60/15 | Managing Patient Dose in Digital Radiology: ICRP Publication 93: Vol.34, No.1 | ICRP |
2004 |
| 6.07.4.60/42 | Marktontwikkeling en leveringszekerheid
voor medische radionucliden, aanvulling | Roobol, de Waard, RIVM |
September 2019 |
| 6.07.4.60/38 | Marktontwikkeling en leveringszekerheid voor medische isotopen | Roobol, de Waard, RIVM |
April 2018 |
| 6.07.4.60/41 | Marktontwikkeling en leveringszekerheid voor medische radionucliden
| Roobol, de Waard, RIVM |
July 2019 |
| 6.07.4.60/44 | Maximum reasonable radioxenon releases from medical isotope production facilities and their effect on monitoring nuclear explosions | Th.W.Bowyer, R.kephart, P.W.Eslinger, J.Friese |
September 2012 |
| 6.07.4.60/16 | Medical Imaging. A discussion paper | A.Sinclair, Medical Devices |
March 1998 |
| 6.07.4.60/40 | Medical isotope production using Lighthouse accelerator | J.W.Blokker |
November 2017 |
